Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks [NA]

View source ↗

Summary

NDPP-NextGen is a clinical trial to reduce intergenerational obesity and diabetes risks. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Overweight or Obesity | NA | Status: RECRUITING